X0508 4 2025-06-02 0001404912 KKR & Co. Inc. KKR 0001081714 KRAVIS HENRY R C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 30 HUDSON YARDS NEW YORK NY 10001 true true Co-Executive Chairman false Common Stock 2025-06-02 4 S 0 1150469 119.8 D 73006022 D Common Stock 2025-06-02 4 S 0 130925 121.67 D 0 I See Footnote Common Stock 1549369 I See Footnote Common Stock 1000000 I See Footnote Common Stock 5810000 I See Footnote Common Stock 15227 I See Footnote Reflects a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $121.35 to $121.9323, inclusive. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. These shares of common stock are held by a limited liability company of which the Reporting Person is the managing member. These shares are held by a limited partnership, whose general partner is a limited liability company, over which the Reporting Person has investment discretion. These shares are held by a grantor retained annuity trust. These shares of common stock are held by a limited partnership (the "Partnership"), which is an entity controlled by the Reporting Person. As previously reported on a Form 4 filed on May 18, 2018, these shares of common stock are being held by the Partnership solely for purposes of future charitable donations. These shares of common stock are held by the Reporting Person's spouse. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended, the Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. In addition to the shares covered by this filing, Mr. Kravis may sell up to an additional 1.5 million shares of common stock of the Issuer during calendar year 2025. Mr. Kravis currently intends to use the proceeds from these sales to fund personal investments and expenses and/or for charitable purposes. As of the date of this filing, except as disclosed herein, Mr. Kravis has no present plan to sell any additional shares. /s/ Christopher Lee, Attorney-in-fact 2025-06-02